We are live on
!
Find out more
PP
PDS Planning Portfolio holdings
AUM
$1.52B
1-Year Est. Return
18.08%
This Fund
S&P 500
This Quarter
Est. Return
-1.5%
1 Year Est. Return
+18.08%
3 Year Est. Return
+48.56%
5 Year Est. Return
+51.38%
10 Year Est. Return
–
AUM
$433M
AUM Growth
+$22.7M
(+5.5%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
51.44%
Holding
218
New
19
Increased
125
Reduced
50
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.53M |
| 2 |
Vanguard Small-Cap Value ETF
VBR
|
+$3.29M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.2M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$2.67M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$2.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bath & Body Works
BBWI
|
+$338K |
| 2 |
Alibaba
BABA
|
+$299K |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$261K |
| 4 |
CRISPR Therapeutics
CRSP
|
+$243K |
| 5 |
SK Telecom
SKM
|
+$239K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.46% |
| 2 | Technology | 4.92% |
| 3 | Financials | 3.69% |
| 4 | Consumer Discretionary | 3.23% |
| 5 | Industrials | 3.02% |
Similar funds
AM
FCM
ARAM
KP
MCIL
KCM
ACL
GAI
PDS Planning's Q3 2021 Portfolio in Review
As of Q3 2021, PDS Planning held 218 positions worth $433M, up 5.5% from $411M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
PDS Planning deployed $30.8M of net new capital in Q3 2021, opening 19 new positions and adding to 125 existing holdings. Its largest new stake was Victoria's Secret: 6,131 shares worth $339K.
By sector, the portfolio is most concentrated in Healthcare at 6.5% of assets, down from 6.8% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Bath & Body Works, an estimated $338K trimmed.
- PDS Planning's largest Q3 2021 buy was Victoria's Secret: 6,131 shares worth $339K.
- PDS Planning added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $3.53M increase.
- PDS Planning's biggest Q3 2021 reduction was Bath & Body Works, cutting an estimated $338K.
- PDS Planning fully exited CRISPR Therapeutics in Q3 2021, selling an estimated $243K.
- PDS Planning's ten largest holdings make up 51% of its $433M portfolio in Q3 2021.
- PDS Planning opened 19 new positions and closed 7 in Q3 2021.
- PDS Planning's portfolio value rose 5.5% quarter-over-quarter to $433M.
Based on PDS Planning's 13F filing for Q3 2021, filed 22 Oct 2021.